An additional measure for quantifying antibiotic use in hospitals

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 5, 2005, Pages 805-808

  Filius, P M G ^a   Liem, T B Y ^a   van der Linden, P D ^b   Janknegt, R ^c   Natsch, S ^d   Vulto, A G ^a   Verbrugh, H A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Apotheek Hagse Ziekenhuizen ^*  (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibiotic usage; Defined daily doses; Selection density; Selection pressure

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; LINCOSAMIDE DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; TRIMETHOPRIM DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DATA ANALYSIS; DRUG UTILIZATION; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL INFECTION; HUMAN; LENGTH OF STAY; MEASUREMENT; NETHERLANDS; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HOSPITALS; HUMANS; NETHERLANDS; PATIENT ADMISSION; PHARMACY SERVICE, HOSPITAL;

EID: 18844402943     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki093     Document Type: Article

References (12)

1. Cosgrove, S. E., Kaye, K. S., Eliopoulous, G. M. et al. (2002). Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Archives of Internal Medicine 162, 185-90.
2. Rubin, M. A. & Samore, M. H. (2002). Antimicrobial use and resistance. Current Infectious Disease Reports 4, 491 -7.
3. Levy, S. B. (2001). Antibiotic resistance: Consequences of inaction. Clinical Infectious Diseases 33, Suppl.3, S124-9.
4. WHO Collaborating Centre for Drug Statistics Methodology (Norway) (2002). Guidelines For ATC Classification and DDDs Assignment. WHO Collaborating Centre, Oslo, Norway.
5. SWAB (2004). NethMap 2004 - Consumption of Antibiotic Agents and Antibiotic Resistance among Medically Important Bacteria in The Netherlands. [On-line.] http://www.swab.nl (15 December 2004, date last accessed).
6. NORM/NORM-VET 2002 (2002). Consumption of Antimicrobial Agents and Occurrence of Resistance in Norway. Tromsø/Oslo 2003. ISSN 1502-2307. University Hospital of North Norway, Tromsø, Norway.
7. SWEDRES 2003 (2003). A Report on Swedish Antibiotic Utilisation and Resistance in Human Medicine. ISSN 1400-3473. Swedish Strategic Programme for the Rational Use of Antimicrobial Agents (STRAMA) and the Swedish Institute for Infectious Disease Control, Solna, Sweden.
8. DANMAP 2003 (2003). Use of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Food Animals, Foods and Humans in Denmark. ISSN 1600-2032. Danish Veterinary Institute, Copenhagen, Denmark.
9. Monnet, D. L., Mölstad, S. & Cars, O. (2004). Defined daily doses of antibiotics reflect antibiotic prescriptions in ambulatory care. Journal of Antimicrobial Chemotherapy 53, 1109-11.
10. Mandy, B., Koutny, E., Cornette, C. et al. (2004). Methodological validation of monitoring indicators of antibiotic use in hospitals. Pharmacy World and Science 26, 90-5.
11. Curtis, C., Marriott, J. & Langley, C. (2004). Development of a prescribing indicator for objective quantification of antibiotic usage in secondary care. Journal of Antimicrobial Chemotherapy 54, 529-33.
12. Schrag, S. J., Pena, C., Fernandez, J. et al. (2001). Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. Journal of the American Medical Association 286, 49-56.